Enanta Pharmaceuticals (ENTA) Deferred Taxes (2014 - 2020)
Enanta Pharmaceuticals (ENTA) posted Deferred Taxes of $15.0 million for Q3 2020, up 576.58% on a QoQ basis from -$3.1 million in Q2 2020, and up 1363.63% year-over-year from $1.0 million in Q4 2019.
Enanta Pharmaceuticals (ENTA) Deferred Taxes (2014 - 2020) Analysis & Trends
Enanta Pharmaceuticals' Deferred Taxes history runs 7 years deep, the most recent figure standing at $15.0 million for Q3 2020.
- Quarterly Deferred Taxes rose 1363.63% year-over-year to $15.0 million in Q3 2020, while the trailing twelve-month figure through Sep 2020 was $10.6 million (up 438.05% YoY) and the FY2021 annual result came in at $345000.0, down 96.75% from the prior year.
- Deferred Taxes was $15.0 million for Q3 2020 at Enanta Pharmaceuticals, up from -$3.1 million in the prior quarter.
- Across five years, Deferred Taxes topped out at $15.0 million in Q3 2020 and bottomed at -$3.8 million in Q2 2017.
- A 5-year average of $263052.6 and a median of -$918000.0 in 2018 frame the typical range for Deferred Taxes.
- Annual changes were most pronounced in 2016 — Deferred Taxes plunged 5816.67% — and 2020, when it soared 1363.63%.
- Enanta Pharmaceuticals' Deferred Taxes stood at -$1.9 million in 2016, then jumped by 239.37% to $2.7 million in 2017, then slumped by 134.49% to -$918000.0 in 2018, then jumped by 171.57% to $657000.0 in 2019, then surged by 2179.15% to $15.0 million in 2020.
- Business Quant data shows ENTA's Deferred Taxes at $15.0 million in Q3 2020, -$3.1 million in Q2 2020, and -$1.9 million in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -65.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 96.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Enanta Pharmaceuticals | 376.07 Mn | 212.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 14.97 Mn |
| Jun 30, 2020 | -3.14 Mn |
| Mar 31, 2020 | -1.88 Mn |
| Dec 31, 2019 | 657,000.00 |
| Sep 30, 2019 | -1.19 Mn |
| Jun 30, 2019 | -1.15 Mn |
| Mar 31, 2019 | 118,000.00 |
| Dec 31, 2018 | -918,000.00 |
| Sep 30, 2018 | -495,000.00 |
| Jun 30, 2018 | -438,000.00 |
| Mar 31, 2018 | 129,000.00 |
| Dec 31, 2017 | 2.66 Mn |
| Sep 30, 2017 | 7.59 Mn |
| Jun 30, 2017 | -3.80 Mn |
| Mar 31, 2017 | -3.53 Mn |
| Dec 31, 2016 | -1.91 Mn |
| Sep 30, 2016 | -2.84 Mn |
| Jun 30, 2016 | 1.27 Mn |
| Mar 31, 2016 | -1.10 Mn |
| Dec 31, 2015 | 382,000.00 |